DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Risperidone


Collection D4 : CTD
Chemical Name Risperidone ( From PubChem : RISPERIDONE )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotApprovedApprovedApprovedNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
410.484 g/mol 0 6 3.5283 True
Structure
InChI InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
InChIKey RAPZEAPATHNIPO-UHFFFAOYSA-N
Links

Gene (31 / 121)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDaffects(abundance)ABCB1
D018967
CTDaffects(response to substance)ABCB1
D018967
CTDincreases(response to substance)ABCB1
D018967
CTDincreases(transport)ABCB1
D018967
CTDdecreases(export)ABCB1
D018967
CTDdecreases(reaction)ABCB1
D018967
CTDdecreases(activity)ABCB1
D018967
CTDdecreases(reaction)ABCG2
D018967
CTDincreases(transport)ABCG2
D018967
CTDincreases(uptake)ABCG2
D018967
CTDaffects(reaction)BDNF
D018967
CTDincreases(expression)BDNF
D018967
CTDincreases(activity)CASP3
D018967
CTDincreases(reaction)CASP3
D018967
CTDincreases(activity)CASP7
D018967
CTDincreases(reaction)CASP7
D018967
CTDdecreases(expression)CRH
D018967
CTDaffects(abundance)CYP2D6
D018967
CTDaffects(abundance)CYP2D6
D018967
CTDaffects(metabolic processing)CYP2D6
D018967
CTDaffects(metabolic processing)CYP2D6
D018967
CTDaffects(response to substance)CYP2D6
D018967
CTDdecreases(hydroxylation)CYP2D6
D018967
CTDdecreases(metabolic processing)CYP2D6
D018967
CTDaffects(abundance)CYP2D6
D018967
CTDaffects(abundance)CYP2D6
D018967
CTDaffects(metabolic processing)CYP2D6
D018967
CTDaffects(metabolic processing)CYP2D6
D018967
CTDaffects(response to substance)CYP2D6
D018967
CTDincreases(metabolic processing)CYP2D6
D018967
CTDincreases(response to substance)CYP2D6
D018967
CTDaffects(response to substance)CYP3A4
D018967
CTDdecreases(reaction)CYP3A4
D018967
CTDincreases(expression)CYP3A4
D018967
CTDincreases(reaction)CYP3A4
D018967
CTDaffects(abundance)CYP3A5
D018967
CTDincreases(metabolic processing)CYP3A5
D018967
CTDaffects(response to substance)DRD2
D018967
CTDincreases(response to substance)DRD2
D018967
CTDincreases(response to substance)DRD2
D018967
CTDincreases(response to substance)DRD2
D018967
CTDaffects(binding)DRD2
D018967
CTDdecreases(activity)DRD2
D018967
CTDaffects(binding)DRD2
D018967
CTDincreases(response to substance)DRD3
D018967
CTDincreases(response to substance)DRD3
D018967
CTDaffects(expression)FSHB
D018967
CTDincreases(expression)HMGCR
D018967
CTDaffects(reaction)HTR2A
D018967
CTDincreases(expression)HTR2A
D018967
CTDincreases(response to substance)HTR2A
D018967
CTDaffects(response to substance)HTR2A
D018967
CTDincreases(response to substance)HTR2A
D018967
CTDaffects(binding)HTR2A
D018967
CTDdecreases(activity)HTR2A
D018967
CTDaffects(binding)HTR2A
D018967
CTDaffects(reaction)HTR2C
D018967
CTDincreases(expression)HTR2C
D018967
CTDaffects(response to substance)HTR2C
D018967
CTDincreases(response to substance)HTR2C
D018967
CTDaffects(reaction)HTR6
D018967
CTDincreases(expression)HTR6
D018967
CTDaffects(binding)HTR7
D018967
CTDdecreases(activity)HTR7
D018967
CTDdecreases(reaction)HTR7
D018967
CTDaffects(binding)HTR7
D018967
CTDdecreases(activity)HTR7
D018967
CTDaffects(binding)HTR7
D018967
CTDdecreases(activity)HTR7
D018967
CTDdecreases(reaction)HTR7
D018967
CTDincreases(abundance)HTR7
D018967
CTDaffects(binding)INHA
D018967
CTDincreases(expression)INHA
D018967
CTDaffects(binding)INHBB
D018967
CTDincreases(expression)INHBB
D018967
CTDincreases(expression)INS
D018967
CTDdecreases(reaction)KCNH2
D018967
CTDincreases(transport)KCNH2
D018967
CTDaffects(response to substance)MAOA
D018967
CTDincreases(response to substance)MAOA
D018967
CTDdecreases(reaction)NR1I2
D018967
CTDincreases(expression)NR1I2
D018967
CTDincreases(reaction)NR1I2
D018967
CTDdecreases(reaction)PRL
D018967
CTDincreases(secretion)PRL
D018967
CTDaffects(reaction)PRL
D018967
CTDincreases(expression)PRL
D018967
CTDaffects(cotreatment)PRL
D018967
CTDincreases(expression)PRL
D018967
CTDincreases(expression)PRL
D018967
CTDincreases(secretion)PRL
D018967
CTDaffects(response to substance)SNAP25
D018967
PubChem PotencyuM3.162CYP2D6-GI(Protien) :
PubChem PotencyuM7.943CYP2D6-GI(Protien) :
PubChem NoneuMCYP2D6-GI(Protien) :
PubChem NoneuMDRD1-GI(Protien) :
PubChem NoneuMDRD2-GI(Protien) :
PubChem NoneuMDRD3-GI(Protien) :
PubChem NoneuMHTR1AGI(Protien) :
PubChem NoneuMHTR1AGI(Protien) :
PubChem NoneuMHTR1BGI(Protien) :
PubChem NoneuMHTR1BGI(Protien) :
PubChem NoneuMHTR1DGI(Protien) :
PubChem NoneuMHTR1DGI(Protien) :
PubChem NoneuMHTR1EGI(Protien) :
PubChem NoneuMHTR1FGI(Protien) :
PubChem NoneuMHTR2AGI(Protien) :
PubChem NoneuMHTR2AGI(Protien) :
PubChem NoneuMHTR2AGI(Protien) :
PubChem NoneuMHTR2CGI(Protien) :
PubChem NoneuMHTR2CGI(Protien) :
PubChem NoneuMHTR6GI(Protien) :
PubChem NoneuMHTR7GI(Protien) :
PubChem NoneuMHTR7GI(Protien) :
PubChem PotencyuM3.162KCNH2GI(Protien) :
PubChem PotencyuM3.162KCNH2GI(Protien) :
ChEMBLAC50nM3162.280CYP2D6
-Target : CHEMBL289
ChEMBLAC50nM7943.280CYP2D6
-Target : CHEMBL289
ChEMBLPotencynM3162.300CYP2D6
-Target : CHEMBL289
ChEMBLPotencynM7943.300CYP2D6
-Target : CHEMBL289
ChEMBLActivity-DRD2
-Target : CHEMBL217
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).